文献速递银屑病与炎症性皮肤病

已消退银屑病中的驻留T细胞引导组织反应并区分临床结局

Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome.
PubMed 文献 · J Invest Dermatol · 2018-03-03

研究利用OKT-3激活皮肤外植体中的T细胞,通过RNA测序和Nanostring转录组分析比较健康与银屑病皮肤的组织反应模式。结果显示IFN诱导的核心通路反应不依赖皮肤炎症状态,而IL-17A诱导通路(包括防御素β2和角蛋白细胞分化标志物)仅在银屑病样本中激活。整合分析表明IL-17主导的组织反应与UVB治疗后早期复发相关,提示对消退病灶T细胞激活的组织反应分层可能为长期免疫调节治疗中的疾病复发提供个体化预测。

要点

  • OKT-3激活皮肤外植体T细胞后,IFN诱导的核心组织反应与皮肤炎症状态无关。
  • IL-17A诱导通路(防御素β2、角蛋白细胞分化标志物)仅在银屑病样本中激活。
  • IL-17主导的组织反应与UVB治疗后早期复发相关,可能用于个体化预测复发。

核心结论

  • IL-17主导的组织反应与UVB治疗后早期复发相关,对消退病灶T细胞激活的组织反应分层可能为长期免疫调节治疗中的疾病复发提供个体化预测。

研究设计与样本

  • 研究使用pan-T细胞激活抗体OKT-3激活皮肤外植体中的T细胞,并以RNA测序和Nanostring转录组分析比较健康皮肤与银屑病皮肤的组织反应模式。

主要发现

  • 以IFN诱导通路为核心的组织反应在健康皮肤和银屑病皮肤中均被触发,与皮肤炎症状态无关。
  • IL-17A诱导通路(包括防御素β2和角蛋白细胞分化标志物)在银屑病样本中被激活。
  • IL-17A与IFN相关反应的整合分析显示,IL-17主导的组织反应与UVB治疗后早期复发相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriasis is driven by focal disruptions of the immune-homeostasis in human skin. Local relapse following cessation of therapy is common and unpredictable, which complicates clinical management of psoriasis. We have previously shown that pathogenic resident T cells accumulate in active and resolved psoriasis, but whether these cells drive psoriasiform tissue reactions is less clear. Here, we activated T cells within skin explants using the pan-T cell activating antibody OKT-3. To explore if T cells induced different tissue response patterns in healthy and psoriasis afflicted skin, transcriptomic analyses were performed with RNA-sequencing and Nanostring. Core tissue responses dominated by IFN-induced pathways were triggered regardless of the inflammatory status of the skin. In contrast, pathways induced by IL-17A, including Defensin beta 2 and keratinocyte differentiation markers, were activated in psoriasis samples. An integrated analysis of IL-17A and IFN-related responses revealed that IL-17 dominated tissue response correlated with early relapse following UVB treatment. Stratification of tissue responses to T cell activation in resolved lesions could potentially offer individualized prediction of disease relapse during long-term immunomodulatory treatment.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Gallais Sérézal I, Classon C, Cheuk S, et al. Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome. J Invest Dermatol. 2018. PMID: 29510191. doi:10.1016/j.jid.2018.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。